Filing Details
- Accession Number:
- 0000899243-21-019763
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-18 16:45:22
- Reporting Period:
- 2021-05-14
- Accepted Time:
- 2021-05-18 16:45:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1816736 | Gemini Therapeutics Inc. | GMTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815308 | Brian Piekos | C/O Gemini Therapeutics, Inc. 300 One Kendall Square, 3Rd Floor Cambridge MA 02139 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-14 | 7,655 | $9.46 | 7,655 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.30 to $9.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
